• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Potential Unconventional Medicines for the Treatment of SARS-CoV-2.

作者信息

Coppola Maurizio, Mondola Raffaella

机构信息

Department of Addiction, ASL CN2, Alba, Italy.

Department of Mental Health, ASL CN1, Saluzzo, Italy.

出版信息

Drug Res (Stuttg). 2020 Jun;70(6):286. doi: 10.1055/a-1170-4624. Epub 2020 May 19.

DOI:10.1055/a-1170-4624
PMID:32428941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7344234/
Abstract
摘要

相似文献

1
Potential Unconventional Medicines for the Treatment of SARS-CoV-2.用于治疗新型冠状病毒的潜在非常规药物。
Drug Res (Stuttg). 2020 Jun;70(6):286. doi: 10.1055/a-1170-4624. Epub 2020 May 19.
2
Drug repositioning is an alternative for the treatment of coronavirus COVID-19.药物重定位是治疗冠状病毒 COVID-19 的一种替代方法。
Int J Antimicrob Agents. 2020 Jun;55(6):105969. doi: 10.1016/j.ijantimicag.2020.105969. Epub 2020 Apr 9.
3
β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19.用于治疗新冠肺炎的β-抑制蛋白偏向性血管紧张素II受体激动剂
Circulation. 2020 Jul 28;142(4):318-320. doi: 10.1161/CIRCULATIONAHA.120.048723. Epub 2020 May 15.
4
Boosting the arsenal against COVID-19 through computational drug repurposing.通过计算药物重新利用增强对抗新冠病毒的手段。
Drug Discov Today. 2020 Jun;25(6):946-948. doi: 10.1016/j.drudis.2020.04.005. Epub 2020 Apr 15.
5
Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?多发性硬化症中干扰素-β的三十年:我们能否将这些信息用于治疗新型冠状病毒2感染?
Front Immunol. 2020 Jun 18;11:1459. doi: 10.3389/fimmu.2020.01459. eCollection 2020.
6
COVID-19: A Defining Moment for Clinical Pharmacology?新型冠状病毒肺炎:临床药理学的决定性时刻?
Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.
7
Rapid repurposing of drugs for COVID-19.用于治疗新冠肺炎的药物快速重新利用。
Science. 2020 May 22;368(6493):829-830. doi: 10.1126/science.abb9332. Epub 2020 May 8.
8
Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.激活TLR7与固有免疫作为对抗新冠疫情的有效方法:咪喹莫特作为一种潜在疗法
Front Immunol. 2020 Jun 11;11:1373. doi: 10.3389/fimmu.2020.01373. eCollection 2020.
9
Teaching Old Drugs New Tricks: Statins for COVID-19?老药新用:他汀类药物治疗 COVID-19?
Cell Metab. 2020 Aug 4;32(2):145-147. doi: 10.1016/j.cmet.2020.07.006.
10
Existing Drugs Might Treat COVID-19.现有药物可能可治疗新冠病毒病。
JAMA. 2020 Jun 9;323(22):2239. doi: 10.1001/jama.2020.9265.

引用本文的文献

1
Dietary foods containing nitric oxide donors can be early curators of SARS-CoV-2 infection: A possible role in the immune system.膳食中含有一氧化氮供体的食物可能是 SARS-CoV-2 感染的早期抑制剂:在免疫系统中的可能作用。
J Food Biochem. 2022 Mar;46(3):e13884. doi: 10.1111/jfbc.13884. Epub 2021 Aug 9.
2
Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19.Mpro的多构象表征确定了有前景的抗COVID-19药物重新利用候选物。
J Mol Model. 2021 Apr 17;27(5):128. doi: 10.1007/s00894-021-04732-1.
3
Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M) of SARS-CoV-2.维甲酰萘醌 A 片段衍生物作为抗严重急性呼吸综合征冠状病毒 2 主蛋白酶 (M) 的潜在治疗先导物的构效关系 (SAR) 和分子动力学研究。
J Mol Model. 2021 Feb 28;27(3):97. doi: 10.1007/s00894-021-04703-6.
4
Tutankhamun's Antimalarial Drug for Covid-19.图坦卡蒙治疗新冠的抗疟药
Drug Res (Stuttg). 2021 Jan;71(1):4-9. doi: 10.1055/a-1274-1264. Epub 2020 Oct 30.

本文引用的文献

1
Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M) inhibitors to unveil a hope against COVID-19.多维计算机筛选策略鉴定天然多酚类化合物作为 SARS-CoV-2 主蛋白酶(Mpro)抑制剂,以期为抗击 COVID-19 带来新希望。
Comput Biol Med. 2022 Jun;145:105452. doi: 10.1016/j.compbiomed.2022.105452. Epub 2022 Mar 26.
2
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.通过计算方法分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的治疗靶点并发现潜在药物
Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27.
3
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
4
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
5
Rutin attenuates inflammatory responses induced by lipopolysaccharide in an in vitro mouse muscle cell (C2C12) model.芦丁可减轻体外小鼠肌肉细胞(C2C12)模型中脂多糖诱导的炎症反应。
Poult Sci. 2019 Jul 1;98(7):2756-2764. doi: 10.3382/ps/pez037.
6
Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice.地奥司明下调小鼠体内T细胞受体、促炎细胞因子的表达以及针对脂多糖诱导的急性肺损伤的核因子κB激活。
Pharmacol Res. 2015 Dec;102:1-11. doi: 10.1016/j.phrs.2015.09.001. Epub 2015 Sep 8.
7
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.雄激素调节的蛋白酶TMPRSS2激活了一个涉及肿瘤微环境成分的蛋白水解级联反应,并促进前列腺癌转移。
Cancer Discov. 2014 Nov;4(11):1310-25. doi: 10.1158/2159-8290.CD-13-1010. Epub 2014 Aug 13.